2009
DOI: 10.1089/ars.2009.2495
|View full text |Cite
|
Sign up to set email alerts
|

Gene and Cell Therapy for Heart Failure

Abstract: Cardiac gene and cell therapy have both entered clinical trials aimed at ameliorating ventricular dysfunction in patients with chronic congestive heart failure. The transduction of myocardial cells with viral constructs encoding a specific cardiomyocyte Ca 2þ pump in the sarcoplasmic reticulum (SR), SRCa 2þ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 142 publications
0
11
0
Order By: Relevance
“…Adenoviruses , which are non-enveloped and contain linear double-stranded DNA, can be easily manipulated and will accept large inserts up to 35 kilobases in size [100]. Adenoviruses can infect host cells with very high efficiency and are capable of generating high levels of gene expression [78].…”
Section: Gene Transfermentioning
confidence: 99%
See 2 more Smart Citations
“…Adenoviruses , which are non-enveloped and contain linear double-stranded DNA, can be easily manipulated and will accept large inserts up to 35 kilobases in size [100]. Adenoviruses can infect host cells with very high efficiency and are capable of generating high levels of gene expression [78].…”
Section: Gene Transfermentioning
confidence: 99%
“…They can readily infect cardiac cells resulting in stable gene expression for up to one year [114], and since they are not known to cause any human disease, very little immune response is triggered [100]. For these reasons, AAV are considered excellent candidates for use in gene therapy in humans [106].…”
Section: Gene Transfermentioning
confidence: 99%
See 1 more Smart Citation
“…In recent years, stem cell technology is gaining pace in the management and regenerative therapy of heart failure. 2 Research on cell-based regenerative therapy has focused on identifying an ideal cellular source. The optimal cell source to create an engineered myocardial patch should be easy to harvest, proliferate under controlled conditions, nonimmunogenic and should have the ability to differentiate into mature, functional cardiomyocyte.…”
Section: Progress and Challenges In Stem Cell Regenerative Therapymentioning
confidence: 99%
“…A number of different vector systems are already available, but each of them has limiting drawbacks [106]. A number of different vector systems are already available, but each of them has limiting drawbacks [106].…”
Section: Gene Therapy and I/rmentioning
confidence: 99%